글로벌 세포 분류 시장 – 2023-2030

Global Cell Sorting Market - 2023-2030

상품코드BT1895
발행기관DataM Intelligence
발행일2023.06.15
페이지 수195 Pages
포맷PDF + EXCEL
커버리지Global

6,525,00011,775,000

보고서 요약(국문)

시장 개요
글로벌 세포 분류 시장은 2022년 2억 3,650만 달러 규모에 도달했으며, 2030년까지 3억 8,980만 달러에 이를 것으로 예상되어 높은 성장세를 보일 전망입니다. 글로벌 세포 분류 시장은 2023년부터 2030년까지 연평균 6.6%의 성장률을 기록할 것으로 예상됩니다.
세포 분류는 연구, 임상 진단 및 치료 분야에서 다양한 응용 가능성을 가지고 있습니다. 줄기세포나 순환 종양 세포와 같은 희귀 세포 집단을 분리하여 추가 분석을 가능하게 합니다. 또한, 세포 기반 의약품 개발이나 면역 세포 연구와 같은 치료 목적으로 특정 세포 유형을 정제하는 것을 용이하게 합니다.
그러나 장비의 높은 가격, 엄격한 규제, 숙련된 인력 부족, 개발도상국에서의 세포 분류 기술에 대한 인식 부족은 세포 분류 시장의 성장을 저해하는 요인으로 작용합니다.

시장 동향
만성 질환 부담 증가가 예측 기간 동안 글로벌 세포 분류 시장 성장을 촉진하고 있습니다.
미국 성인의 약 60%가 하나 이상의 만성 질환을 앓고 있습니다. 미국에서 주요 사망 원인에는 당뇨병, 암, 심혈관 질환과 같은 만성 질환이 포함됩니다. 심장병, 암, 뇌졸중, 만성 폐쇄성 폐질환, 당뇨병은 전체 사망 원인의 3분의 2 이상을 차지합니다.
미국 질병통제예방센터(CDC)에 따르면, 미국의 연간 의료비 3조 8천억 달러 중 90%는 만성 질환 및 정신 건강 문제를 가진 사람들에게서 발생합니다. 만성 질환 퇴치를 위한 파트너십(Partnership to Fight Chronic Disease)의 최근 보고서에 따르면, 2030년까지 미국에서 가장 흔한 7가지 만성 질환 치료에 드는 비용은 연간 총 2조 달러, 즉 1인당 8,600달러에 달할 것으로 예상됩니다. 같은 보고서에 따르면, 유해한 행동을 줄이면 매년 110만 명의 사망을 예방할 수 있습니다.

성장하는 바이오제약 산업이 예측 기간 동안 글로벌 세포 분류 시장 성장을 견인하고 있습니다.
미국에서 가장 큰 산업 중 하나인 바이오제약 산업은 매년 수십억 달러 규모이며 미국 경제와 제품을 사용하는 환자들에게 매우 중요합니다. 이 산업은 CDMO 바이오제약 회사의 등장으로 엄청난 성장을 경험하고 있으며, 이들 회사는 이전보다 훨씬 빠르게 의약품을 생산하고 있습니다.
이 산업의 성장은 세계 인구 증가에도 기인합니다. 세계 인구의 수요 증가는 바이오제약 사업에 압력을 가하고 있지만, 동시에 더 많은 투자를 유치하고 수익성을 높이며 사업을 확장할 수 있도록 해줍니다.
맞춤형 의학의 확장은 글로벌 세포 분류 시장의 성장 기회를 제공합니다.
맞춤형 의학을 통해 진단, 치료 및 예방에 대한 "획일적인" 접근 방식을 개별화된 접근 방식으로 전환할 수 있습니다. 환자 고유의 특성에 기반한 표적 치료가 맞춤형 의학의 목표입니다. 맞춤형 치료를 위해 특정 세포 유형을 식별하고 분리하는 것은 세포 분류 기술에 크게 의존합니다. 개인 맞춤형 의학이 성장함에 따라 세포 분류 기술에 대한 수요가 증가할 것으로 예상됩니다.
COVID-19 영향 분석
COVID-19 팬데믹은 세포 분류 시장에 긍정적인 영향을 미쳤습니다. 면역 반응의 다양성과 COVID-19가 다양한 세포 유형에 미치는 영향은 세포 분류를 포함한 단일 세포 분석 기술을 사용하여 광범위하게 연구되었습니다. 팬데믹은 개별 세포의 특성과 반응을 이해해야 할 필요성을 강조함으로써 단일 세포 분석 기술을 발전시키고 세포 분류 기술에 대한 수요를 증가시켰습니다.
러시아-우크라이나 분쟁 분석
러시아-우크라이나 전쟁이 세포 분류 시장에 미치는 영향은 복잡하고 다면적입니다. 분쟁과 그 여파로 인해 피해 지역의 의료 인프라 구축에 필요한 자원, 관심, 재정이 다른 곳으로 분산될 수 있습니다. 이는 세포 분류와 같은 최첨단 기술이 의료 및 연구 분야에서 채택되고 사용되는 방식에 영향을 미칠 수 있습니다.
세분화 분석
글로벌 세포 분류 시장은 기술, 제품 및 서비스, 응용 분야, 최종 사용자 및 지역별로 세분화됩니다.

형광활성세포분류(FACS) 부문은 예측 기간 동안 시장에서 지배적인 위치를 유지할 것으로 예상됩니다.
형광활성세포분류(FACS) 부문은 2022년 세포분류 시장의 약 43.6%를 차지하며 가장 높은 시장 점유율을 기록했습니다. 유세포 분석 기술인 형광활성세포분류(FACS)는 특수한 방법으로, 각 세포의 고유한 광산란 및 형광 특성을 이용하여 다양한 살아있는 세포 혼합물을 한 번에 하나의 세포씩 두 개 이상의 용기로 분리할 수 있게 해줍니다.
이 기술은 개별 세포의 형광 신호를 빠르고 정확하며 정량적으로 기록할 뿐만 아니라 특정 관심 세포를 물리적으로 분리할 수 있게 해주기 때문에 실용적인 과학 도구입니다.

지리적 분석
주요 기업들의 협력 및 신제품 출시 증가와 FDA 승인 증가로 북미 지역 시장이 주도
북미는 세포 분류 시장의 약 39.6%를 차지하며 시장을 주도할 것으로 예상됩니다. 시장 참여 기업들은 신제품 출시 및 협력과 같은 전략을 통해 사업을 확장하고 있습니다.
예를 들어, 과학 분야 선도 기업인 Thermo Fisher Scientific은 2023년 1월 인도에서 Bigfoot Spectral Cell Sorter를 출시했습니다. 이 혁신적인 세포 분류 시스템은 스펙트럼 분류 및 분석 기술을 기존 분류 방식과 결합하여 빠르고 간편하게 세포를 분류할 수 있도록 합니다.
경쟁 환경
시장의 주요 글로벌 기업으로는 Bio-Rad Laboratories, Inc., Sony Biotechnology Inc., BD, Merck KGaA, Danaher Corporation, Miltenyi Biotec GmbH, Affymetrix, Inc., Sysmex Partec GmbH, On-Chip Biotechnologies Co., Ltd., Thermo Fisher Scientific 등이 있습니다.
보고서 ​​구매 이유

• 기술, 제품 및 서비스, 응용 분야, 최종 사용자, 지역별 글로벌 세포 분류 시장 세분화를 시각화하고 주요 상업 자산 및 주요 업체를 파악합니다.

• 트렌드 및 공동 개발 분석을 통해 사업 기회를 식별합니다.

• 모든 세그먼트를 포함한 세포 분류 시장 수준의 다양한 데이터가 담긴 Excel 데이터 시트를 제공합니다.

• 심층적인 질적 인터뷰와 연구를 바탕으로 종합적인 분석 결과를 담은 PDF 보고서를 제공합니다.

• 주요 업체들의 핵심 제품을 모두 포함하는 제품 맵핑 Excel 파일을 제공합니다.

글로벌 세포 분류 시장 보고서는 약 69개의 표, 70개의 그림, 195페이지 분량입니다.
주요 대상 고객 (2023년 기준)
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Market Overview
The Global Cell Sorting Market reached US$ 236.5 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 389.8 million by 2030. The Global Cell Sorting Market is expected to exhibit a CAGR of 6.6% during the forecast period 2023-2030.
Cell sorting has numerous applications in research, clinical diagnostics, and therapeutics. It makes it possible to separate rare cell groups, including stem cells or circulating tumor cells, for further analysis. Additionally, it makes it easier to purify particular cell types for therapeutic uses like developing cell-based medicines or researching immune cell populations.
However, the high cost of devices, stringent regulations, lack of skilled personnel and lack of awareness of cell sorting technology in developing countries are some factors hindering the growth of the cell sorting market.
Market Dynamics
The Rising Chronic Disease Burden is Boosting the Global Cell Sorting Market Growth During the Forecast Period
Nearly 60% of American adults suffer from at least one chronic illness. The major causes of death in the US include chronic diseases like diabetes, cancer, and cardiovascular disease. Heart disease, cancer, stroke, chronic obstructive pulmonary disease, and diabetes account for over two-thirds of all fatalities.
According to the CDC, 90% of the nation's $3.8 trillion in annual healthcare costs are attributable to persons with chronic illnesses and mental health issues. According to a recent report by the Partnership to Fight Chronic Disease, by 2030, the expense of treating the seven most prevalent chronic diseases in the United States will total $2 trillion annually or $8,600 per person. According to the same report, reducing harmful behaviors might prevent 1,100,000 deaths annually.
The Growing Biopharmaceutical Industry is Boosting the Global Cell Sorting Market Growth During the Forecast Period
One of the largest industries in America is biopharma, which is worth billions of dollars annually and is crucial to the American economy and the patients who use their products. This business is experiencing tremendous expansion due to the emergence of CDMO Biologics companies, which are generating pharmaceuticals more quickly than before.
The expansion of this industry is also attributed to an expanding world population. The demand from the world's population has increased pressure on the biopharma business, but it has also allowed it to attract more investment, increase profitability, and expand.
The Expansion of Personalized Medicine Provides the Global Cell Sorting Market Growth Opportunities
With personalized medicine, it's possible to transform a "one size fits all" approach to diagnosis, medication, and prevention into an individualized one. Targeted treatments based on unique patient traits are the goal of personalized medicine. Identifying and isolating particular cell types for customized therapeutics depend heavily on cell sorting technology. The demand for cell sorting technology is anticipated to rise as personalized medicine grows.
COVID-19 Impact Analysis
The COVID-19 pandemic has had a positive impact on the cell sorting market. The variability of the immune response and the effects of COVID-19 on various cell types have been extensively studied using single-cell analytic techniques, including cell sorting. The pandemic has enhanced single-cell analysis techniques and increased demand for cell sorting technology by highlighting the need to comprehend individual cells' traits and reactions.
Russia-Ukraine Conflict Analysis
The impact of the Russia-Ukraine war on the cell sorting market is complex and multifaceted. Resources, attention, and finance for the construction of healthcare infrastructure in the impacted areas may be diverted by the conflict and its aftermath. This might affect how cutting-edge technologies, like cell sorting, are adopted and used in healthcare and research contexts.
Segment Analysis
The Global Cell Sorting Market is segmented based on technology, product and services, application, End-user, and region.
The Fluorescence-Activated Cell Sorting (FACS) Segment is Expected to Hold a Dominant Position in the Market Over the Forecast Period
The fluorescence-activated cell sorting (FACS) segment accounted for the highest market stake, accounting for approximately 43.6% of the cell sorting market in 2022. The flow cytometry technique, fluorescence-activated cell sorting (FACS), is specialized. Using the unique light scattering and fluorescence properties of each cell, it offers a way for dividing a heterogeneous mixture of living cells into two or more containers, one cell at a time.
It is a practical scientific tool since it allows for the quick, accurate, and quantitative recording of fluorescence signals from individual cells as well as the physical segregation of cells of specific interest.
Geographical Analysis
Increasing Collaborations And Product Launches by the Key Players, and Increasing FDA Approvals, Dominate the North American Region
North America is expected to dominate the cell sorting market, accounting for around 39.6%. The market player applies strategies such as product launches and collaboration to expand their business.
For instance, in January 2023, Thermo Fisher Scientific, the leader in serving science, launched the Bigfoot Spectral Cell Sorter in India. The groundbreaking cell sorting system combines spectral sorting and analysis with traditional sorting to produce quick, simple-to-use cell sorting.
Competitive Landscape
The major global players in the market include Bio-Rad Laboratories, Inc., Sony Biotechnology Inc., BD, Merck KGaA, Danaher Corporation, Miltenyi Biotec GmbH, Affymetrix, Inc., Sysmex Partec GmbH, On-Chip Biotechnologies Co., Ltd., Thermo Fisher Scientific among others.
Why Purchase the Report?
• To visualize the Global Cell Sorting Market segmentation based on the technology, product and services, application, End-user, and region and understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of cell sorting market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.
The Global Cell Sorting Market Report Would Provide Approximately 69 Tables, 70 Figures And 195 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Technology
3.2. Snippet by Product and Services
3.3. Snippet by Application
3.4. Snippet by End-user
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing number of chronic disease testing
4.1.2. Restraints
4.1.2.1. High costs and services
4.1.3. Opportunity
4.1.3.1. Technological advancements
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Unmet Needs
5.4. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID-19
6.1.2. Scenario During COVID-19
6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers’ Strategic Initiatives
6.6. Conclusion
7. Russia-Ukraine War Analysis
8. Artificial Intelligence Analysis
9. By Technology
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.1.2. Market Attractiveness Index, By Technology
9.2. Fluorescence-activated cell sorting (FACS)*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Magnetic-activated cell sorting (MACS)
9.4. Micro-Electromechanical Systems (MEMS) Microfluidics
9.5. Density Gradient Centrifugation
9.6. Immunodensity Cell Separation
9.7. Sedimentation
9.8. Others
10. By Product and Services
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Services
10.1.2. Market Attractiveness Index, By Product and Services
10.2. Cell Sorters*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Cell Sorting Reagents & Consumables
10.4. Cell Sorting Services
11. By Application
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.1.2. Market Attractiveness Index, By Application
11.2. Clinical Applications*
11.2.1. Introduction
11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Research Applications
11.3.1. Immunology & Cancer Research
11.3.2. Stem Cell Research
11.3.3. Drug Discovery
11.3.4. Other Research Applications
12. By End user
12.1. Introduction
12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
12.1.2. Market Attractiveness Index, By End user
12.2. Research Institutes*
12.2.1. Introduction
12.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
12.3. Pharmaceutical & Biotechnology Companies
12.4. Hospitals and Clinical Testing Laboratories
12.5. Medical Schools and Academic Institutions
13. By Region
13.1. Introduction
13.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
13.1.2. Market Attractiveness Index, By Region
13.2. North America
13.2.1. Introduction
13.2.2. Key Region-Specific Dynamics
13.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
13.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Services
13.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
13.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
13.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.2.7.1. The U.S.
13.2.7.2. Canada
13.2.7.3. Mexico
13.3. Europe
13.3.1. Introduction
13.3.2. Key Region-Specific Dynamics
13.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
13.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Services
13.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
13.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
13.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.3.7.1. Germany
13.3.7.2. The U.K.
13.3.7.3. France
13.3.7.4. Italy
13.3.7.5. Spain
13.3.7.6. Rest of Europe
13.4. South America
13.4.1. Introduction
13.4.2. Key Region-Specific Dynamics
13.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
13.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Services
13.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
13.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
13.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.4.7.1. Brazil
13.4.7.2. Argentina
13.4.7.3. Rest of South America
13.5. Asia-Pacific
13.5.1. Introduction
13.5.2. Key Region-Specific Dynamics
13.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
13.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Services
13.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
13.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
13.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.5.7.1. China
13.5.7.2. India
13.5.7.3. Japan
13.5.7.4. Australia
13.5.7.5. Rest of Asia-Pacific
13.6. Middle East and Africa
13.6.1. Introduction
13.6.2. Key Region-Specific Dynamics
13.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
13.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Services
13.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
13.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
14. Competitive Landscape
14.1. Competitive Scenario
14.2. Product Benchmarking
14.3. Company Share Analysis
14.4. Key Developments and Strategies
15. Company Profiles
15.1. Bio-Rad Laboratories, Inc.*
15.1.1. Company Overview
15.1.2. Product Portfolio and Description
15.1.3. Financial Overview
15.1.4. Key Developments
15.2. Sony Biotechnology Inc.
15.3. BD
15.4. Merck KGaA
15.5. Danaher Corporation
15.6. Miltenyi Biotec GmbH
15.7. Affymetrix, Inc
15.8. Sysmex Partec GmbH
15.9. On-Chip Biotechnologies Co., Ltd.
15.10. Thermo Fisher Scientific
LIST NOT EXHAUSTIVE
16. Appendix
16.1. About Us and Services
16.2. Contact Us

언급된 주요 기업들

Bio-Rad Laboratories, Inc., 4. Key Developments, Sony Biotechnology Inc., BD, Merck KGaA, Danaher Corporation, Miltenyi Biotec GmbH, Affymetrix, Inc, Sysmex Partec GmbH, On-Chip Biotechnologies Co., Ltd., Thermo Fisher Scientific

표 목록 (Tables)

List of Tables

Table 1 Global Cell Sorting Market Value, By Technology, 2023, 2027 & 2031 (US$ Million)

Table 2 Global Cell Sorting Market Value, By Product and Services, 2023, 2027 & 2031 (US$ Million)

Table 3 Global Cell Sorting Market Value, By Application, 2023, 2027 & 2031 (US$ Million)

Table 4 Global Cell Sorting Market Value, By End user, 2023, 2027 & 2031 (US$ Million)

Table 5 Global Cell Sorting Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 6 Global Cell Sorting Market Value, By Technology, 2023, 2027 & 2031 (US$ Million)

Table 7 Global Cell Sorting Market Value, By Technology, 2022-2031 (US$ Million)

Table 8 Global Cell Sorting Market Value, By Product and Services, 2023, 2027 & 2031 (US$ Million)

Table 9 Global Cell Sorting Market Value, By Product and Services, 2022-2031 (US$ Million)

Table 10 Global Cell Sorting Market Value, By Application, 2023, 2027 & 2031 (US$ Million)

Table 11 Global Cell Sorting Market Value, By Application, 2022-2031 (US$ Million)

Table 12 Global Cell Sorting Market Value, By End user, 2023, 2027 & 2031 (US$ Million)

Table 13 Global Cell Sorting Market Value, By End user, 2022-2031 (US$ Million)

Table 14 Global Cell Sorting Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 15 Global Cell Sorting Market Value, By Region, 2022-2031 (US$ Million)

Table 16 North America Cell Sorting Market Value, By Technology, 2022-2031 (US$ Million)

Table 17 North America Cell Sorting Market Value, By Product and Services, 2022-2031 (US$ Million)

Table 18 North America Cell Sorting Market Value, By Application, 2022-2031 (US$ Million)

Table 19 North America Cell Sorting Market Value, By End user, 2022-2031 (US$ Million)

Table 20 North America Cell Sorting Market Value, By Country, 2022-2031 (US$ Million)

Table 21 South America Cell Sorting Market Value, By Technology, 2022-2031 (US$ Million)

Table 22 South America Cell Sorting Market Value, By Product and Services, 2022-2031 (US$ Million)

Table 23 South America Cell Sorting Market Value, By Application, 2022-2031 (US$ Million)

Table 24 South America Cell Sorting Market Value, By End user, 2022-2031 (US$ Million)

Table 25 South America Cell Sorting Market Value, By Country, 2022-2031 (US$ Million)

Table 26 Europe Cell Sorting Market Value, By Technology, 2022-2031 (US$ Million)

Table 27 Europe Cell Sorting Market Value, By Product and Services, 2022-2031 (US$ Million)

Table 28 Europe Cell Sorting Market Value, By Application, 2022-2031 (US$ Million)

Table 29 Europe Cell Sorting Market Value, By End user, 2022-2031 (US$ Million)

Table 30 Europe Cell Sorting Market Value, By Country, 2022-2031 (US$ Million)

Table 31 Asia-Pacific Cell Sorting Market Value, By Technology, 2022-2031 (US$ Million)

Table 32 Asia-Pacific Cell Sorting Market Value, By Product and Services, 2022-2031 (US$ Million)

Table 33 Asia-Pacific Cell Sorting Market Value, By Application, 2022-2031 (US$ Million)

Table 34 Asia-Pacific Cell Sorting Market Value, By End user, 2022-2031 (US$ Million)

Table 35 Asia-Pacific Cell Sorting Market Value, By Country, 2022-2031 (US$ Million)

Table 36 Middle East & Africa Cell Sorting Market Value, By Technology, 2022-2031 (US$ Million)

Table 37 Middle East & Africa Cell Sorting Market Value, By Product and Services, 2022-2031 (US$ Million)

Table 38 Middle East & Africa Cell Sorting Market Value, By Application, 2022-2031 (US$ Million)

Table 39 Middle East & Africa Cell Sorting Market Value, By End user, 2022-2031 (US$ Million)

Table 40 Bio-Rad Laboratories, Inc.: Overview

Table 41 Bio-Rad Laboratories, Inc.: Product Portfolio

Table 42 Bio-Rad Laboratories, Inc.: Key Developments

Table 43 Sony Biotechnology Inc.: Overview

Table 44 Sony Biotechnology Inc.: Product Portfolio

Table 45 Sony Biotechnology Inc.: Key Developments

Table 46 BD: Overview

Table 47 BD: Product Portfolio

Table 48 BD: Key Developments

Table 49 Merck KGaA: Overview

Table 50 Merck KGaA: Product Portfolio

Table 51 Merck KGaA: Key Developments

Table 52 Danaher Corporation: Overview

Table 53 Danaher Corporation: Product Portfolio

Table 54 Danaher Corporation: Key Developments

Table 55 Miltenyi Biotec GmbH: Overview

Table 56 Miltenyi Biotec GmbH: Product Portfolio

Table 57 Miltenyi Biotec GmbH: Key Developments

Table 58 Affymetrix, Inc: Overview

Table 59 Affymetrix, Inc: Product Portfolio

Table 60 Affymetrix, Inc: Key Developments

Table 61 Sysmex Partec GmbH: Overview

Table 62 Sysmex Partec GmbH: Product Portfolio

Table 63 Sysmex Partec GmbH: Key Developments

Table 64 On-Chip Biotechnologies Co., Ltd.: Overview

Table 65 On-Chip Biotechnologies Co., Ltd.: Product Portfolio

Table 66 On-Chip Biotechnologies Co., Ltd.: Key Developments

Table 67 Thermo Fisher Scientific: Overview

Table 68 Thermo Fisher Scientific: Product Portfolio

Table 69 Thermo Fisher Scientific: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Cell Sorting Market Value, 2022-2031 (US$ Million)

Figure 2 Global Cell Sorting Market Share, By Technology, 2022 & 2031 (%)

Figure 3 Global Cell Sorting Market Share, By Product and Services, 2022 & 2031 (%)

Figure 4 Global Cell Sorting Market Share, By Application, 2022 & 2031 (%)

Figure 5 Global Cell Sorting Market Share, By End user, 2022 & 2031 (%)

Figure 6 Global Cell Sorting Market Share, By Region, 2022 & 2031 (%)

Figure 7 Global Cell Sorting Market Y-o-Y Growth, By Technology, 2022-2031 (%)

Figure 8 Fluorescence activated cell sorting (FACS) Cell Sorting Market Value, 2022-2031 (US$ Million)

Figure 9 Magnetic activated cell sorting (MACS) Cell Sorting Market Value, 2022-2031 (US$ Million)

Figure 10 Micro-Electromechanical Systems (MEMS) Microfluidics Cell Sorting Market Value, 2022-2031 (US$ Million)

Figure 11 Density Gradient Centrifugation Cell Sorting Market Value, 2022-2031 (US$ Million)

Figure 12 Immunodensity Cell Separation Cell Sorting Market Value, 2022-2031 (US$ Million)

Figure 13 Sedimentation Cell Sorting Market Value, 2022-2031 (US$ Million)

Figure 14 Global Cell Sorting Market Y-o-Y Growth, By Product and Services, 2022-2031 (%)

Figure 15 Cell Sorters Product and Services in Global Cell Sorting Market Value, 2022-2031 (US$ Million)

Figure 16 Cell Sorting Reagents & Consumables Product and Services in Global Cell Sorting Market Value, 2022-2031 (US$ Million)

Figure 17 Cell Sorting Services Product and Services in Global Cell Sorting Market Value, 2022-2031 (US$ Million)

Figure 18 Global Cell Sorting Market Y-o-Y Growth, By Application, 2022-2031 (%)

Figure 19 Clinical Applications Application in Global Cell Sorting Market Value, 2022-2031 (US$ Million)

Figure 20 Research Applications Application in Global Cell Sorting Market Value, 2022-2031 (US$ Million)

Figure 21 Global Cell Sorting Market Y-o-Y Growth, By End user, 2022-2031 (%)

Figure 22 Research Institutes End-user in Global Cell Sorting Market Value, 2022-2031 (US$ Million)

Figure 23 Pharmaceutical & Biotechnology Companies End-user in Global Cell Sorting Market Value, 2022-2031 (US$ Million)

Figure 24 Hospitals and Clinical Testing Laboratories End-user in Global Cell Sorting Market Value, 2022-2031 (US$ Million)

Figure 25 Medical Schools and Academic Institutions End-user in Global Cell Sorting Market Value, 2022-2031 (US$ Million)

Figure 26 Global Cell Sorting Market Y-o-Y Growth, By Region, 2022-2031 (%)

Figure 27 North America Cell Sorting Market Value, 2022-2031 (US$ Million)

Figure 28 Asia-Pacific Cell Sorting Market Value, 2022-2031 (US$ Million)

Figure 29 Europe Cell Sorting Market Value, 2022-2031 (US$ Million)

Figure 30 South America Cell Sorting Market Value, 2022-2031 (US$ Million)

Figure 31 Middle East and Africa Cell Sorting Market Value, 2022-2031 (US$ Million)

Figure 32 North America Cell Sorting Market Value, 2022-2031 (US$ Million)

Figure 33 North America Cell Sorting Market Share, By Technology, 2022 & 2031 (%)

Figure 34 North America Cell Sorting Market Share, By Product and Services, 2022 & 2031 (%)

Figure 35 North America Cell Sorting Market Share, By Application, 2022 & 2031 (%)

Figure 36 North America Cell Sorting Market Share, By End user, 2022 & 2031 (%)

Figure 37 North America Cell Sorting Market Share, By Country, 2022 & 2031 (%)

Figure 38 South America Cell Sorting Market Value, 2022-2031 (US$ Million)

Figure 39 South America Cell Sorting Market Share, By Technology, 2022 & 2031 (%)

Figure 40 South America Cell Sorting Market Share, By Product and Services, 2022 & 2031 (%)

Figure 41 South America Cell Sorting Market Share, By Application, 2022 & 2031 (%)

Figure 42 South America Cell Sorting Market Share, By End user, 2022 & 2031 (%)

Figure 43 South America Cell Sorting Market Share, By Country, 2022 & 2031 (%)

Figure 44 Europe Cell Sorting Market Value, 2022-2031 (US$ Million)

Figure 45 Europe Cell Sorting Market Share, By Technology, 2022 & 2031 (%)

Figure 46 Europe Cell Sorting Market Share, By Product and Services, 2022 & 2031 (%)

Figure 47 Europe Cell Sorting Market Share, By Application, 2022 & 2031 (%)

Figure 48 Europe Cell Sorting Market Share, By End user, 2022 & 2031 (%)

Figure 49 Europe Cell Sorting Market Share, By Country, 2022 & 2031 (%)

Figure 50 Asia-Pacific Cell Sorting Market Value, 2022-2031 (US$ Million)

Figure 51 Asia-Pacific Cell Sorting Market Share, By Technology, 2022 & 2031 (%)

Figure 52 Asia-Pacific Cell Sorting Market Share, By Product and Services, 2022 & 2031 (%)

Figure 53 Asia-Pacific Cell Sorting Market Share, By Application, 2022 & 2031 (%)

Figure 54 Asia-Pacific Cell Sorting Market Share, By End user, 2022 & 2031 (%)

Figure 55 Asia-Pacific Cell Sorting Market Share, By Country, 2022 & 2031 (%)

Figure 56 Middle East & Africa Cell Sorting Market Value, 2022-2031 (US$ Million)

Figure 57 Middle East & Africa Cell Sorting Market Share, By Technology, 2022 & 2031 (%)

Figure 58 Middle East & Africa Cell Sorting Market Share, By Product and Services, 2022 & 2031 (%)

Figure 59 Middle East & Africa Cell Sorting Market Share, By Application, 2022 & 2031 (%)

Figure 60 Middle East & Africa Cell Sorting Market Share, By End user, 2022 & 2031 (%)

Figure 61 Bio-Rad Laboratories, Inc.: Financials

Figure 62 Sony Biotechnology Inc.: Financials

Figure 63 BD: Financials

Figure 64 Merck KGaA: Financials

Figure 65 Danaher Corporation: Financials

Figure 66 Miltenyi Biotec GmbH: Financials

Figure 67 Affymetrix, Inc: Financials

Figure 68 Sysmex Partec GmbH: Financials

Figure 69 On-Chip Biotechnologies Co., Ltd.: Financials

Figure 70 Thermo Fisher Scientific: Financials